Official Publications Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq 00:00:00 12/09/2026 +04			5-day change	1st Jan Change
32.47 ^USD	+0.74%		-3.36%	+5.42%

09-08	Espiria Hållbar Framtid rose 4.5 percent in August, Vestas and Hansa Biopharma made positive contributions	FW
09-08	Barclays raises Genmab price target to 2,900 Danish kroner (2,500), reiterates overweight - BN	FW

09-08	Extraordinary general shareholder meeting	CO
08-06	Slide show half-year results	CO
08-06	1st-half-year results	CO
05-07	Slide show Q1	CO
05-07	1st quarter results	CO
03-19	Minutes of the general assembly	CO
02-17	Annual Report	CO
11-19	Director/PDMR/Person closely associated - Disposal/Sale	CO
11-06	3rd quarter results	CO
23/09/25	Threshold crossings	CO
09/09/25	Director/PDMR/Person closely associated - Purchase/Subscription	CO
07/08/25	Half-year report	CO
01/07/25	Changes in management and corporate officers	CO
30/06/25	Share buyback	CO
23/06/25	Share buyback	CO
17/06/25	Director/PDMR/Person closely associated - Disposal/Sale	CO
16/06/25	Share buyback	CO
10/06/25	Share buyback	CO
02/06/25	Share buyback	CO
26/05/25	Share buyback	CO
19/05/25	Share buyback	CO
12/05/25	Share buyback	CO
08/05/25	1st quarter results	CO
05/05/25	Share buyback	CO
14/04/25	Share buyback	CO